Cellular Immunity Is Critical for Assessing COVID-19 Vaccine Effectiveness in Immunocompromised Individuals
COVID-19 vaccine clinical development was conducted with unprecedented speed. Immunity measurements were concentrated on the antibody response which left significant gaps in our understanding how robust and long-lasting immune protection develops. Better understanding the cellular immune response wi...
Main Authors: | Eustache Paramithiotis, Scott Sugden, Eszter Papp, Marie Bonhomme, Todd Chermak, Stephanie Y. Crawford, Stefanie Z. Demetriades, Gerson Galdos, Bruce L. Lambert, John Mattison, Thomas McDade, Stephane Pillet, Robert Murphy |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.880784/full |
Similar Items
-
The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials
by: Robert L. Murphy, et al.
Published: (2022-09-01) -
Integrated antibody and cellular immunity monitoring are required for assessment of the long term protection that will be essential for effective next generation vaccine development
by: Eustache Paramithiotis, et al.
Published: (2023-11-01) -
Rhino-Orbito-Cerebral Mucormycosis in an Immunocompromised Patient
by: Heung Eog Cha, et al.
Published: (2022-07-01) -
Fatal sepsis by Bacillus circulans in an immunocompromised patient
by: M Alebouyeh, et al.
Published: (2011-09-01) -
Pulmonary tuberculosis in the immunocompromised patients
by: Vukosav Danijela, et al.
Published: (2019-01-01)